Ticker: BEAM

Company: Beam Therapeutics Inc.

Person: Bethany J Cavanagh, officer

Transaction date: Jan. 22, 2026

Reporting date: Jan. 26, 2026

Average share price: 35.0005

Sold 6198.0 shares for 216933.1